voltageg
potassium
channel
express
cardiac
tissu
coassembl
auxiliari
subunit
mediat
slowli
activ
current
acceler
repolar
action
potenti
cardiomyocyt
mutat
gene
result
reduct
loss
channel
activ
caus
prolong
repolar
action
potenti
therebi
caus
long
qt
syndrom
lqt
small
molecul
activ
use
understand
mechan
complex
activ
develop
therapeut
lqt
studi
report
hexachlorophen
hcp
activ
compon
topic
antiinfect
prescript
drug
phisohex
activ
hcp
potent
increas
current
amplitud
express
stabil
channel
open
state
ec
mm
studi
cardiomyocyt
show
hcp
significantli
shorten
action
potenti
durat
mm
addit
hcp
capabl
rescu
loss
function
lqt
mutant
caus
either
impair
activ
gate
bind
affin
result
indic
hcp
novel
activ
may
use
tool
compound
develop
lqt
therapeut
kcnq
channel
voltageg
potassium
channel
mediat
subthreshold
noninactiv
voltageg
potassium
current
import
role
control
membran
excit
five
known
isoform
one
predominantli
express
heart
pore
form
subunit
tetramer
complex
give
rise
function
channel
nativ
cell
cardiomyocyt
coassembl
nonconduct
accessori
subunit
small
singl
transmembran
protein
encod
gene
heteromultimer
propos
mediat
slowli
activ
current
acceler
repolar
action
potenti
cardiac
tissu
also
known
ik
lossoffunct
mutat
lead
long
qt
syndrom
lqt
sever
arrhythmia
character
abnorm
cardiac
repolar
lead
prolong
qt
interv
sever
lqt
vari
syncop
sudden
death
lqt
either
congenit
acquir
congenit
lqt
case
lqt
occur
exercis
link
mutat
gene
genet
studi
lqt
patient
identifi
least
mutat
includ
missens
nonsens
delet
frame
shift
splice
mutat
potenti
channel
small
molecul
activ
thought
potenti
attract
strategi
treat
lqt
recent
number
activ
kcnq
channel
report
howev
activ
still
rare
effect
physiolog
relev
complex
two
known
exampl
includ
zinc
pyrithion
znpi
potenti
homomer
channel
lack
sensit
complex
date
three
small
molecul
activ
complex
identifi
mefenam
acid
mfa
did
phenylboron
acid
pba
initi
mfa
did
identifi
chlorid
channel
blocker
compound
strongli
potenti
exhibit
littl
effect
homomer
contrast
pba
aromat
deriv
boron
acid
potenti
homomer
complex
millimolar
effect
concentr
screen
collect
drug
drug
candid
homomer
kcnq
channel
identifi
hcp
one
activ
compound
hcp
also
known
nabac
activ
compon
phisohex
topic
antiinfect
prescript
drug
found
homomer
complex
sensit
hcp
micromolar
concentr
effect
complex
much
potent
homomer
studi
show
hcp
effect
cardiomyocyt
capabl
rescu
lqt
mutant
taken
togeth
studi
indic
hcp
effect
activ
cell
cultur
transfect
cho
cell
grown
gibco
fetal
bovin
serum
fb
mm
lglutamin
invitrogen
express
channel
mutant
cell
split
h
transfect
plate
dish
transfect
lipofectamin
tm
reagent
invitrogen
accord
manufactur
instruct
gfp
cdna
amaxa
gaithersburg
md
cotransfect
identifi
transfect
cell
fluoresc
microscopi
fluxor
thallium
assay
cho
cell
stabli
express
rat
routin
cultur
medium
supplement
fb
mgml
fluxor
thallium
assay
protocol
manufactur
protocol
cell
seed
well
plate
cellswel
grown
confluenc
co
incub
medium
remov
follow
day
ml
fluxor
load
buffer
ad
well
min
room
temperatur
rt
dark
remov
load
buffer
mlwell
assay
buffer
mlwell
controltest
compound
ad
cell
rt
dark
compound
test
prepar
use
assay
buffer
control
assay
buffer
ec
ec
retigabin
ec
min
cell
plate
load
fdss
second
record
mlwell
stimulu
buffer
ad
plate
read
everi
second
stimulu
buffer
contain
mm
mm
tl
gpotenti
r
test
r
control
r
control
r
buffer
calcul
well
use
second
fluoresc
ratio
identifi
compound
potenti
activ
kcnq
channel
thallium
flux
assay
develop
use
screen
microsourc
tm
librari
compound
mm
final
concentr
pilot
screen
hcp
exhibit
strong
potenti
fluoresc
signal
record
current
express
kcnq
channel
cho
cell
standard
wholecel
record
use
pipett
pull
borosil
glass
capillari
world
precis
instrument
fill
intracellular
solut
pipett
resist
megaohm
record
constant
perfus
extracellular
solut
maintain
use
bp
perfus
system
ala
scientif
instrument
pipett
solut
contain
mm
kcl
mgcl
egta
hepe
mgatp
ph
extracellular
solut
contain
mm
nacl
kcl
cacl
mgcl
hepe
glucos
ph
current
voltag
record
use
amplifi
filter
khz
digit
use
digidata
pclamp
softwar
axon
instrument
seri
resist
compens
also
use
set
anim
procedur
perform
accord
nation
institut
heath
guid
care
use
laboratori
anim
protocol
approv
strictli
follow
institut
anim
care
use
committe
iacuc
iacuc
check
protocol
approv
studi
singl
myocyt
isol
left
ventricl
adult
guinea
pig
langerdorff
perfus
system
previous
describ
heart
remov
quickli
via
midlin
thoracotomi
perfus
ca
free
tyrod
solut
contain
collagenas
mgml
proteas
mgml
patch
clamp
data
process
use
clampfit
molecular
devic
sunnyval
ca
analyz
graphpad
prism
graphpad
softwar
san
diego
ca
voltagedepend
activ
curv
fit
boltzmann
equat
g
g
min
g
max
g
min
vv
g
max
maximum
conduct
g
min
minimum
conduct
v
voltag
reach
maximum
conduct
slope
factor
doserespons
curv
fit
hill
equat
e
e
max
ec
c
p
ec
drug
concentr
produc
half
maximum
respons
p
hill
coeffici
data
present
mean
sd
signific
estim
use
unpair
twotail
student
test
effect
consid
signific
structur
hcp
distinct
previous
report
activ
fig
obtain
better
understand
hcp
activ
kcnq
channel
examin
effect
isoform
electrophysiolog
elicit
current
fix
mv
depolar
use
test
channel
tabl
summar
mm
hcp
potenti
indic
outward
current
hcp
potenti
test
channel
except
fig
notic
hcp
significantli
potenti
complex
ii
valu
respect
effect
hcp
gv
curv
subtyp
examin
summar
tabl
uniqu
subtyp
select
ie
strong
homomer
mediat
characterist
outward
current
detect
inactiv
fig
presenc
mm
hcp
steadyst
outward
current
differ
depolar
voltag
greatli
potenti
potenti
channel
mediat
previou
report
activ
znpi
involv
hyperpolar
shift
v
determin
hcp
effect
homomer
examin
gv
curv
absenc
presenc
mm
hcp
applic
hcp
v
valu
mv
fig
applic
hcp
v
valu
shift
mv
leftshift
around
mv
inactiv
distinct
featur
inhibit
inactiv
activ
znpi
thought
contribut
factor
overal
increas
novel
activ
hexachlorophen
plo
one
wwwplosoneorg
current
amplitud
analyz
inactiv
kinet
differ
depolar
step
found
detect
differ
applic
hcp
fig
henc
hcp
increas
overal
conduct
leftshift
gv
curv
affect
inactiv
addit
hcp
also
induc
delay
deactiv
hyperpolar
voltag
fig
presenc
mm
hcp
time
constant
deactiv
slow
ms
ms
n
reduct
deactiv
rate
consist
overal
increas
current
amplitud
g
max
examin
hcp
modul
complex
coexpress
cdna
cho
cell
consist
previou
report
effect
includ
increas
overal
current
amplitud
slow
activ
deactiv
kinet
remov
inactiv
fig
test
hcp
effect
mv
potenti
elicit
channel
found
presenc
mm
hcp
around
second
larg
instantan
current
becam
evid
final
outward
current
potenti
around
fold
much
higher
fig
similar
effect
hcp
also
slow
deactiv
complex
fig
leftshift
gv
curv
fig
analysi
doserespons
curv
hcp
complex
reveal
ec
valu
mm
hcp
potenti
complex
test
effect
ik
acut
isol
guinea
pig
cardiomyocyt
found
applic
mm
hcp
ik
increas
fold
n
mv
measur
potenti
gv
curv
left
shift
mv
n
fig
b
c
effect
hcp
action
potenti
examin
action
potenti
elicit
isol
guinea
pig
ventricular
myocyt
current
inject
upon
applic
mm
hcp
action
potenti
durat
apd
shorten
consist
apd
action
potenti
durat
repolar
apd
action
potenti
durat
repolar
shorten
respect
n
fig
f
inhibitori
effect
restor
five
minut
remov
compound
revers
choromon
blocker
ik
choromon
mm
alon
prolong
apd
around
n
coapplic
mm
choromon
action
potenti
durat
restor
n
fig
accordingli
effect
mm
hcp
apd
reduc
n
hcp
mm
effect
caus
reduct
action
potenti
durat
chang
apd
apd
apd
respect
n
report
ik
activ
shorten
apd
effect
test
posit
control
system
mm
mm
significantli
deceas
apd
n
n
fig
consist
previou
studi
thu
data
consist
notion
hcp
act
nativ
kcnq
channel
mutat
found
caus
lqt
common
phenotyp
mutant
reduct
ik
current
commonli
thought
mediat
complex
result
decreas
either
channel
activ
traffick
effici
hcp
exhibit
potent
effect
homomer
complex
thu
hypothes
abil
rescu
function
reduct
mutant
select
express
four
mutant
locat
differ
region
among
mutant
exhibit
low
consist
current
other
exhibit
detect
current
cho
cell
locat
near
ctermin
end
transmembran
domain
locat
ctermin
tail
mutat
thought
impair
activ
gate
reduc
bind
affin
respect
current
studi
homomer
mutant
channel
significantli
potenti
mm
hcp
potenti
compar
wild
type
fig
tabl
next
test
whether
hcp
effect
mutant
found
complex
also
sensit
mm
hcp
outward
current
potenti
n
n
fold
respect
effect
hcp
voltagedepend
activ
mutant
channel
also
examin
result
shown
tabl
besid
gv
curv
test
mutant
channel
leftshift
mm
hcp
hcp
also
known
nabac
activ
compon
phisohex
prescript
drug
wide
use
effect
antibacteri
skin
cleanser
treatment
acn
previou
studi
hcp
identifi
inhibitor
enoylacyl
carrier
protein
reductas
proteas
sarscov
also
found
attenu
wntbcatenin
signal
pathway
play
import
role
cell
prolifer
differenti
oncogenesi
current
studi
identifi
hcp
activ
kcnq
channel
among
report
activ
kcnq
channel
hcp
exhibit
uniqu
subtyp
select
potenti
outward
current
homomer
kcnq
channel
mv
hcp
lack
sensit
wellcharacter
kcnq
activ
retigabin
lack
sensit
anoth
kcnq
activ
distinct
retigabin
znpi
potenti
affect
although
znpi
show
similar
select
hcp
ie
potenti
kcnq
isoform
except
znpi
lack
sensit
complex
express
heterolog
system
show
hcp
exhibit
potent
effect
complex
uniqu
subtyp
select
support
hcp
may
potenti
kcnq
channel
differ
mechan
known
activ
hcp
repres
novel
class
activ
potenti
homomer
channel
low
concentr
affect
complex
interestingli
potenti
effect
complex
seem
depend
ratio
increas
ratio
caus
notic
reduct
activ
alanin
scan
reveal
may
interact
specif
residu
locat
transmembran
domain
subunit
consist
previou
studi
show
residu
critic
potenti
effect
cluster
togeth
region
proxim
critic
residu
znpi
differ
znpi
hcp
potenti
homomer
complex
mefenam
acid
did
pba
report
activ
although
three
compound
exhibit
potent
effect
complex
similar
hcp
phenotyp
three
activ
easili
differenti
hcp
mefenam
acid
did
also
caus
instantan
open
complex
howev
mefenam
acid
did
effect
homomer
much
weaker
hcp
leftshift
gv
curv
slow
deactiv
increas
overal
conduct
homomer
differ
hcp
significantli
increas
overal
conduct
homomer
fig
pba
potenti
interest
pba
exhibit
inhibitori
effect
initi
gradual
potenti
effect
homomer
complex
argu
pba
hcp
act
via
differ
mechan
interest
pba
hcp
slow
rate
effect
reach
steadi
state
difficult
wash
taken
togeth
result
suggest
hcp
may
repres
novel
class
activ
current
therapi
lqt
inadequ
critic
role
current
mediat
repolar
cardiac
action
potenti
augment
small
molecul
may
repres
attract
strategi
treat
lqt
studi
found
mm
hcp
effect
potenti
nativ
ik
leftshift
gv
curv
ik
activ
instantan
higher
concentr
hcp
includ
mm
mm
effect
hcp
shorten
action
potenti
durat
cardiomyocyt
support
potenti
use
develop
therapeut
lqt
either
tool
compound
lead
compound
slight
reduct
action
potenti
amplitud
suggest
hcp
may
affect
channel
lqt
caus
mutat
among
identifi
lqtassoci
gene
includ
herg
mutat
caus
reduct
potassium
current
therebi
lead
prolong
cardiac
repolar
mani
mutat
lqt
traffick
plasma
membran
suggest
major
fold
defect
reduct
activ
among
test
mutant
novel
identifi
mutat
locat
linker
thought
affect
activ
gate
traffick
defici
mutat
locat
ctermin
end
loss
function
consist
previou
report
missens
mutat
locat
transmembran
segment
implic
activ
gate
potassium
channel
suppress
current
consist
notion
mutat
prevent
normal
channel
gate
addit
mutant
identifi
patient
dominantli
inherit
classic
long
qt
romanoward
syndrom
locat
ctermin
tail
show
reduc
bind
affin
demonstr
necessari
function
variou
ion
channel
includ
kcnq
channel
recent
studi
show
affin
reduc
potenti
suggest
hcp
capabl
restor
lossoffunct
caus
variou
mutat
either
impair
gate
reduc
affin
howev
effect
hcp
mutant
channel
weaker
wild
type
channel
wild
type
channel
mm
hcp
dramat
left
shift
gv
curv
around
mv
contrast
left
shift
mv
furthermor
case
shift
neglig
consid
physiolog
effici
activ
kcnq
channel
reli
effect
gv
relationship
weaker
loss
effect
hcp
gv
curv
mutant
channel
consid
major
factor
develop
therapeut
lqt
conclus
identifi
hcp
activ
compon
prescript
drug
potent
kcnq
channel
activ
uniqu
subtyp
select
exhibit
strong
potenti
effect
homomer
complex
distinct
pharmacolog
phenotyp
chemic
structur
hcp
report
activ
suggest
hcp
repres
novel
class
activ
activ
shorten
action
potenti
durat
abil
rescu
lossoffunct
lqt
mutant
make
hcp
use
tool
develop
therapeut
lqt
